Safeguard Scientifics Inc
Safeguard Scientifics Inc is a diversified holding company that invests in and manages a portfolio of technology and life sciences businesses, primarily generating revenue through equity stakes and operational income from its subsidiaries.
Business. Safeguard Scientifics Inc (SFES.PK) is a diversified investment management firm operating within the Financials sector. The company generates revenue primarily through fee-based models associated with asset management activities. It is listed on the OTC market under the ticker SFES.PK. Specific details regarding operating segments, headquarters location, and geographic breakdowns are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Safeguard Scientifics Inc (SFES.PK) is a diversified investment management firm operating within the Financials sector. The company generates revenue primarily through fee-based models associated with asset management activities. It is listed on the OTC market under the ticker SFES.PK. Specific details regarding operating segments, headquarters location, and geographic breakdowns are not provided in the available data.
Safeguard Scientifics Inc exhibits a strong capital structure with a current ratio of 22.67, indicating a high level of liquidity and the ability to cover short-term liabilities many times over. The company has no long-term debt, and its cash and equivalents amount to $19.4 million, which is a significant portion of its total assets of $46.2 million. This liquidity position is further supported by a debt-to-equity ratio of 0.0, suggesting a conservative capital structure with no leverage.
Profitability metrics for Safeguard Scientifics Inc are negative, with a return on equity (ROE) of -15.41% and a return on assets (ROA) of -14.52%. These figures indicate that the company is not generating returns for its shareholders and is underperforming relative to industry norms. The negative operating income of $1.23 million and net income of -$6.71 million further underscore the company's current unprofitability.
The company's revenue is derived from a diversified portfolio of technology and life sciences businesses, though specific segment details are not disclosed in the available data. Geographically, the company's exposure is not explicitly outlined, but its operations are likely concentrated in the United States given its listing and primary market.
Looking ahead, the company's growth trajectory is uncertain. The current fiscal year is expected to show a continuation of the negative trends, with no significant improvement in operating cash flow, which was -$1.00 million in the latest period. The lack of positive cash flow and the absence of long-term debt suggest that the company is not currently expanding through capital-intensive projects or acquisitions.
Risk factors for Safeguard Scientifics Inc include its unprofitable operations and the potential for continued negative returns on equity and assets. The company's liquidity is strong, but its profitability is a concern. There is no immediate dilution risk, as the number of shares outstanding has not changed between basic and diluted shares. The company has not made any recent adjustments to its valuation metrics, and there are no filing-based liquidity or dilution flags.
Recent events for Safeguard Scientifics Inc include the latest financial reporting period, which shows a continuation of the company's unprofitable operations. There are no recent filings or transcripts indicating significant changes in strategy or operations. The company's focus remains on managing its portfolio of investments and subsidiaries, with no immediate plans for major restructuring or expansion.
- Safeguard Scientifics Inc has a strong liquidity position with a current ratio of 22.67 and no long-term debt.
- The company is currently unprofitable, with a negative return on equity and assets.
- There is no immediate dilution risk, as the number of shares outstanding has not changed.
- The company's growth trajectory is uncertain, with no significant improvement in operating cash flow.
- The company's operations are likely concentrated in the United States, with a focus on technology and life sciences businesses.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Operating income -$1.0M.
- ▍Operating income -$1.0M
Operating income -$1.4M.
- ▍Operating income -$1.4M
Operating income -$1.1M.
- ▍Operating income -$1.1M
Operating income -$1.2M.
- ▍Operating income -$1.2M
Operating income +60,6% YoY; Net income −152,8% YoY.
- ▍Operating income +60,6% YoY
- ▍Net income −152,8% YoY
Operating income +37,5% YoY; Net income +171,8% YoY.
- ▍Operating income +37,5% YoY
- ▍Net income +171,8% YoY
Operating income −127,4% YoY; Net income −168,9% YoY.
- ▍Operating income −127,4% YoY
- ▍Net income −168,9% YoY
- ▍Free cash flow −208,4% YoY
Operating income -$13.0M.
- ▍Operating income -$13.0M
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Return On Assetsnet_income / total_assets
- Safeguard Scientifics Inc Market data — financials · 2026-05-29
Ownership & reference
Insider activity
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Operating income (YoY) (2023-12-31 vs 2022-12-31): -19.0%Derived (calculated)
- EPS (basic) (YoY) (2023-12-31 vs 2022-12-31): 29.9%Derived (calculated)
- Total liabilities (YoY) (2023-12-31 vs 2022-12-31): -8.3%Derived (calculated)
- Total assets (YoY) (2023-12-31 vs 2022-12-31): -39.4%Derived (calculated)
- EPS (diluted) (YoY) (2023-12-31 vs 2022-12-31): 29.9%Derived (calculated)
- Current ratio (FY 2023-12-31): 4.84xDerived (calculated)
- Cash & equivalents (YoY) (2023-12-31 vs 2022-12-31): -28.8%Derived (calculated)
- Operating cash flow (YoY) (2023-12-31 vs 2022-12-31): -1.5%Derived (calculated)
- EPS (diluted) (annual): USD-PER-SHARES -1SEC XBRL filing
- Pre-tax income (annual): USD -9.83MSEC XBRL filing
- Current liabilities (annual): USD 2.05MSEC XBRL filing
- Operating cash flow (annual): USD -3.31MSEC XBRL filing
- Current assets (annual): USD 9.91MSEC XBRL filing
- Total assets (annual): USD 22.84MSEC XBRL filing
- EPS (basic) (annual): USD-PER-SHARES -1SEC XBRL filing
- Total liabilities (annual): USD 2.86MSEC XBRL filing
- Cash & equivalents (annual): USD 9.5MSEC XBRL filing
- Operating income (annual): USD -5.68MSEC XBRL filing
- EPS (basic) (YoY) (2022-12-31 vs 2021-12-31): -164.0%Derived (calculated)
- Operating income (YoY) (2022-12-31 vs 2021-12-31): 33.2%Derived (calculated)
- Total assets (YoY) (2022-12-31 vs 2021-12-31): -30.2%Derived (calculated)
- Total liabilities (YoY) (2022-12-31 vs 2021-12-31): -10.0%Derived (calculated)
- Cash & equivalents (YoY) (2022-12-31 vs 2021-12-31): -46.1%Derived (calculated)
- EPS (diluted) (YoY) (2022-12-31 vs 2021-12-31): -164.0%Derived (calculated)